Loading...
Gene Therapy Expansion Will Transform Rare Disease Therapeutics
AnalystHighTarget's Fair Value
US$22.00
63.6% undervalued intrinsic discount11 Sep
US$8.01
1Y
-28.5%7D
1.5%1Y
-28.5%7D
1.5%You can edit this narrative until Aug 27 9:34 PM. Then, changes will post as Updates.